Literature DB >> 6121571

Can we develop new drugs for hypertension?

F Gross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6121571      PMCID： PMC1401776          DOI： 10.1111/j.1365-2125.1982.tb01348.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  A new beta 2-adrenoceptor agonist with alpha 1-adrenoceptor blocking properties.

Authors:  O A Olsson; B Ahlquist; B Gustafsson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1981-04

2.  [Studies on the influence of the antihypertensive drug urapidil on blood circulation and its regulation in animal experiments (author's transl)].

Authors:  W Schoetensack; P Bischler; E C Dittmann; V Steinijans
Journal:  Arzneimittelforschung       Date:  1977

3.  Drug therapy of hypertension: what we have, what we need, what we expect.

Authors:  F Gross
Journal:  Am J Cardiol       Date:  1974-10-01       Impact factor: 2.778

4.  Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.

Authors:  J Burton; R J Cody; J A Herd; E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  Inhibition of the renin-angiotensinogen reaction by pepstatin.

Authors:  F Gross; J Lazar; H Orth
Journal:  Science       Date:  1972-02-11       Impact factor: 47.728
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.